116 related articles for article (PubMed ID: 3209306)
1. Immunoscintigraphy with 131I-labelled HMFG2 and HMFG1 F(ab')2 in the pre-operative detection of clinical and subclinical lymph node metastases in breast cancer patients.
Athanassiou A; Pectasides D; Pateniotis K; Tzimis L; Natsis P; Lafi A; Arapantoni P; Koutsiouba P; Taylor-Papadimitriou J; Epenetos A
Int J Cancer Suppl; 1988; 3():89-95. PubMed ID: 3209306
[TBL] [Abstract][Full Text] [Related]
2. Immunoscintigraphy with 131I-labelled monoclonal antibodies HMFG2 and HMFG1 F(ab')2 versus abdominal CT scan in the detection of residual disease in ovarian cancer patients.
Pectasides D; Pateniotis K; Tzimis L; Trapalli X; Natsis P; Arapantoni P; Taylor-Papadimitriou J; Epenetos A; Koutsiouba P; Athanassiou A
Int J Cancer Suppl; 1988; 3():83-8. PubMed ID: 3209305
[TBL] [Abstract][Full Text] [Related]
3. Kinetics, quantitative analysis and radioimmunolocalization using indium-111-HMFG1 monoclonal antibody in patients with breast cancer.
Kalofonos HP; Sackier JM; Hatzistylianou M; Pervez S; Taylor-Papadimitriou J; Waxman JH; Lavender JP; Wood C; Epenetos AA
Br J Cancer; 1989 Jun; 59(6):939-42. PubMed ID: 2736231
[TBL] [Abstract][Full Text] [Related]
4. The detection of axillary lymph node metastases from breast cancer by radiolabelled monoclonal antibodies: a prospective study.
Tjandra JJ; Sacks NP; Thompson CH; Leyden MJ; Stacker SA; Lichtenstein M; Russell IS; Collins JP; Andrews JT; Pietersz GA
Br J Cancer; 1989 Feb; 59(2):296-302. PubMed ID: 2930695
[TBL] [Abstract][Full Text] [Related]
5. Combined use of 123I-labelled BCD-F9 and 4C4 monoclonal antibody with dissimilar specificity for breast cancer: implication for the detection limit of immunolymphoscintigraphy in the assessment of axillary lymph node metastases.
Schatten C; Barrada M; Mandeville R; Enzelsberger H; Angelberger P; Czerwenka K; Kubista E; Pateisky N
Nucl Med Commun; 1994 Jun; 15(6):422-9. PubMed ID: 8078637
[TBL] [Abstract][Full Text] [Related]
6. Immunolymphoscintigraphy and immunoscintigraphy of ovarian and fallopian tube cancer using F(ab')2 fragments of monoclonal antibody OC 125.
Lehtovirta P; Kairemo KJ; Liewendahl K; Seppälä M
Cancer Res; 1990 Feb; 50(3 Suppl):937s-940s. PubMed ID: 2297745
[TBL] [Abstract][Full Text] [Related]
7. Imaging with 131I-labeled monoclonal antibodies to a high-molecular-weight melanoma-associated antigen in patients with melanoma: efficacy of whole immunoglobulin and its F(ab')2 fragments.
Buraggi GL; Callegaro L; Mariani G; Turrin A; Cascinelli N; Attili A; Bombardieri E; Terno G; Plassio G; Dovis M
Cancer Res; 1985 Jul; 45(7):3378-87. PubMed ID: 4005860
[TBL] [Abstract][Full Text] [Related]
8. Immunoscintigraphy for detection of lymph node metastases from breast cancer.
Thompson CH; Lichtenstein M; Stacker SA; Leyden MJ; Salehi N; Andrews JT; McKenzie IF
Lancet; 1984 Dec; 2(8414):1245-7. PubMed ID: 6150280
[TBL] [Abstract][Full Text] [Related]
9. Superior localisation and imaging of radiolabelled monoclonal antibody E48 F(ab')2 fragment in xenografts of human squamous cell carcinoma of the head and neck and of the vulva as compared to monoclonal antibody E48 IgG.
Gerretsen M; Quak JJ; Suh JS; van Walsum M; Meijer CJ; Snow GB; van Dongen GA
Br J Cancer; 1991 Jan; 63(1):37-44. PubMed ID: 1989663
[TBL] [Abstract][Full Text] [Related]
10. Improved immunoscintigraphy by subcutaneous injection of 99mTc or 111In labelled F(ab')2 fragments of an anti-melanoma monoclonal antibody.
Paganelli G; Riva P; Moscatelli G; Stacchiotti A; Agostini M; Landi G; Tison V; Pancea P; Siccardi AG
Int J Rad Appl Instrum B; 1986; 13(4):423-8. PubMed ID: 3793497
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the pharmacokinetics, biodistribution and dosimetry of monoclonal antibodies OC125, OV-TL 3, and 139H2 as IgG and F(ab')2 fragments in experimental ovarian cancer.
Molthoff CF; Pinedo HM; Schlüper HM; Nijman HW; Boven E
Br J Cancer; 1992 May; 65(5):677-83. PubMed ID: 1586596
[TBL] [Abstract][Full Text] [Related]
12. Radioiodination of murine anti-alpha-foetoprotein E.9 monoclonal antibody and its F(ab')2 fragment for the diagnosis of hepatocellular carcinoma.
Beyers M; Aspinall S; Conradie JD; Fourie PJ
Nuklearmedizin; 1988 Jun; 27(3):87-94. PubMed ID: 2457207
[TBL] [Abstract][Full Text] [Related]
13. Biodistribution of radiolabeled monoclonal antibody E48 IgG and F(ab')2 in patients with head and neck cancer.
de Bree R; Roos JC; Quak JJ; den Hollander W; Wilhelm AJ; van Lingen A; Snow GB; Dongen GA
Clin Cancer Res; 1995 Mar; 1(3):277-86. PubMed ID: 9815983
[TBL] [Abstract][Full Text] [Related]
14. Clinical value of immunolymphscintigraphy in patients with breast cancer.
Schatten C; Pateisky N; Enzelsberger H; Grouix B; Mandeville R
In Vivo; 1988; 2(5):321-4. PubMed ID: 2979852
[TBL] [Abstract][Full Text] [Related]
15. Binding parameters and idiotypic profile of the whole immunoglobulin and Fab' fragments of murine monoclonal antibody to distinct determinants of the human high molecular weight-melanoma associated antigen.
Temponi M; Gold AM; Ferrone S
Cancer Res; 1992 May; 52(9):2497-503. PubMed ID: 1373670
[TBL] [Abstract][Full Text] [Related]
16. Immunoscintigraphy of recurrences of gynecologic carcinomas.
Chatal JF; Fumoleau P; Saccavini JC; Thedrez P; Curtet C; Bianco-Arco A; Chetanneau A; Peltier P; Kremer M; Guillard Y
J Nucl Med; 1987 Dec; 28(12):1807-19. PubMed ID: 3500284
[TBL] [Abstract][Full Text] [Related]
17. Immunolymphscintigraphy of axillary lymph node metastases in breast cancer patients using monoclonal antibodies: first clinical findings.
Mandeville R; Pateisky N; Philipp K; Kubista E; Dumas F; Grouix B
Anticancer Res; 1986; 6(6):1257-63. PubMed ID: 3813482
[TBL] [Abstract][Full Text] [Related]
18. Biodistribution and planar gamma camera imaging of (123)I- and (131)I-labeled F(ab')(2) and Fab fragments of monoclonal antibody 14C5 in nude mice bearing an A549 lung tumor.
Burvenich IJ; Schoonooghe S; Blanckaert P; Bacher K; Vervoort L; Coene E; Mertens N; De Vos F; Slegers G
Nucl Med Biol; 2007 Apr; 34(3):257-65. PubMed ID: 17383575
[TBL] [Abstract][Full Text] [Related]
19. Antibody-guided diagnosis and therapy of malignant lesions.
Kalofonos HP; Stewart S; Epenetos AA
Int J Cancer Suppl; 1988; 2():74-80. PubMed ID: 3162448
[TBL] [Abstract][Full Text] [Related]
20. Radioimmunodetection of lymph node invasion in prostatic cancer. The use of iodine 123 (123I)-labeled monoclonal anti-prostatic acid phosphatase (PAP) 227 A F(ab')2 antibody fragments in vivo.
Leroy M; Teillac P; Rain JD; Saccavini JC; Le Duc A; Najean Y
Cancer; 1989 Jul; 64(1):1-5. PubMed ID: 2731106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
